Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Net Income: 2023-2024

Historic Net Income for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $1.7 billion.

  • Inhibrx Biosciences' Net Income rose 19.62% to -$35.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$155.1 million, marking a year-over-year decrease of 109.44%. This contributed to the annual value of $1.7 billion for FY2024, which is 803.96% up from last year.
  • As of FY2024, Inhibrx Biosciences' Net Income stood at $1.7 billion, which was up 803.96% from -$239.7 million recorded in FY2023.
  • In the past 5 years, Inhibrx Biosciences' Net Income registered a high of $1.7 billion during FY2024, and its lowest value of -$239.7 million during FY2023.
  • Over the past 2 years, Inhibrx Biosciences' median Net Income value was $723.9 million (recorded in 2023), while the average stood at $723.9 million.
  • Data for Inhibrx Biosciences' Net Income shows a peak YoY surged of 803.96% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Net Income stood at -$239.7 million in 2023, then spiked by 803.96% to $1.7 billion in 2024.